← Leaderboards
Marc R Moon
Washington University
$2,323,688
Attributed
$2,323,688
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $380K · FY2008–11$500K$375K$250K$125K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$2,323,688 · 2
By mechanism
R01$2,323,688 · 2
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Ralph J Damiano$12,132,872
- Colin G Nichols$27,441,621
- Jeanne M Nerbonne$23,263,404
- Spencer J Melby$97,224
- Richard B Schuessler$1,745,077
Others in their field
Top investigators on “Heart Function”
- William George Nelson · Johns Hopkins University$80,153,436
- Adrian Hernandez · Duke University$64,563,543
- Thomas A Buchanan · University Of Southern California$59,802,734
- Pamela Susan Douglas · Duke University$55,346,639
- Vasan S. Ramachandran · Boston University Medical Campus$48,626,699
- Philip A Wolf · Boston University Medical Campus$41,343,335
Research focus
Heart FunctionHeart FailureCardiac OutputCalcium Channel BlockersPulmonary HypertensionEvaluation3-DimensionalExposure ToBloodAgonistAnimalsDirect Patient CareBaseAdrenergic AgentsCause Of DeathCathetersCessation Of LifeChronicBiomechanicsClenbuterolContractsDecision MakingDesignAdrenergic Receptor
Grant awards (7)
RIGHT HEART FUNCTION IN PULMONARY HYPERTENSION WITH BETA-AGONIST AND ATRIAL SHUNT$380,000
R01 · FY2011 · HL · contact PI
RIGHT HEART FUNCTION IN PULMONARY HYPERTENSION WITH BETA-AGONIST AND ATRIAL SHUNT$380,000
R01 · FY2010 · HL · contact PI
RIGHT HEART FUNCTION IN PULMONARY HYPERTENSION WITH BETA-AGONIST AND ATRIAL SHUNT$380,000
R01 · FY2009 · HL · contact PI
RIGHT HEART FUNCTION IN PULMONARY HYPERTENSION WITH BETA-AGONIST AND ATRIAL SHUNT$380,000
R01 · FY2008 · HL · contact PI
Pathophysiology and Treatment of Pulmonary Hypertension$267,750
R01 · FY2004 · HL
Pathophysiology and Treatment of Pulmonary Hypertension$267,750
R01 · FY2003 · HL
Pathophysiology and Treatment of Pulmonary Hypertension$268,188
R01 · FY2002 · HL